Published in Biotech Law Weekly, July 23rd, 2004
According to a study from the United States, "Dendritic cells (DCs) have been shown to require a degree of maturation to stimulate antigen-specific, type I cytotoxic T lymphocytes in numerous murine models. Limited data in humans suggest that immature DCs (DC) can induce tolerance, yet a variety of nonmatured DC used clinically have induced antigen-specific type I T cells in vivo to various tumor-associated antigens."
"Use of adenovirus to engineer DCs is an efficient method for delivery of entire genes to DC," L. Schumacher and colleagues reported,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.